Americans Encounter Risks at Psychedelic Clinics Abroad

Participants, often in vulnerable states, have little recourse if mistreated or injured.
Participants, often in vulnerable states, have little recourse if mistreated or injured.
Related Articles
HealthWhy Drug Companies Are Rushing to Market Ketamine Medicines
Spurred on by the Trump administration’s embrace of psychedelic medicine, researchers are experimenting with new — and not so new — forms of the anesthetic.
HealthNew Cancer Drugs Are Revolutionary. Why Don’t More Patients Get Them?
Targeted gene therapies are highly effective at stopping cancers, but the very abundance of the treatments, plus cost and sluggish change, are hindering access.


